Actively Recruiting
Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer
Led by VA Office of Research and Development · Updated on 2026-01-27
40
Participants Needed
1
Research Sites
63 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Lung cancer is the second-most commonly diagnosed cancer among U.S. Veterans. Substantial advances have been made in early detection through screening and treatment. The longevity of Veterans following lung cancer diagnosis and treatment has increased. Following treatment however, many Veterans experience increased symptom burden, particularly in shortness of breath, fatigue, and fear/anxiety about lung cancer, and impairments in physical and psychosocial functioning. Rehabilitation services are needed to address these survivorship challenges. This study will evaluate multi-targeted telerehabilitation with Veterans following lung cancer treatment, with goals to reduce symptom burden, improve physical and psychosocial function, and enhance health-related quality of life. This research will also develop the career of a physician researcher to acquire expertise in rehabilitation for many Veteran survivors of lung and other cancers.
CONDITIONS
Official Title
Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult Veterans with a history of stage I-III A/B lung cancer
- Completed curative intent therapy (lung cancer surgery, definitive radiation, or concurrent chemoradiation) within 1 to 6 months
You will not qualify if you...
- Presence of orthopedic conditions that prevent exercise participation, such as bilateral below-knee amputation
- Severe cardiopulmonary disease, including unstable arrhythmias like ventricular tachycardia, heart failure with ejection fraction below 25%, or chronic hypoxemia requiring more than 5 L/min oxygen at rest
- Inability to follow directions or provide informed consent due to conditions like moderate to severe dementia
- Current enrollment in hospice care
- Estimated life expectancy less than 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado, United States, 80045-7211
Actively Recruiting
Research Team
D
Duc M Ha, MD MAS
CONTACT
R
Robert L Keith, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here